H.C. Wainwright Reiterates Buy Rating on TG Therapeutics (TGTX)

September 19, 2024 6:45 AM EDT Send to a Friend
H.C. Wainwright analyst Edward White reiterated a Buy rating and $49.00 price target on TG Therapeutics (NASDAQ: TGTX).The analyst commented ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login